ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 126 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $3,473,000 | +28.8% | 935,987 | 0.0% | 0.04% | +29.6% |
| Q4 2017 | $2,696,000 | -35.9% | 935,987 | 0.0% | 0.03% | -43.8% |
| Q3 2017 | $4,203,000 | +33.9% | 935,987 | +36.9% | 0.05% | +23.1% |
| Q2 2017 | $3,138,000 | +1229.7% | 683,619 | +2241.6% | 0.04% | +875.0% |
| Q3 2016 | $236,000 | +3.5% | 29,194 | 0.0% | 0.00% | -20.0% |
| Q2 2016 | $228,000 | +1.3% | 29,194 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $225,000 | -32.4% | 29,194 | -5.3% | 0.01% | -44.4% |
| Q4 2015 | $333,000 | +56.3% | 30,844 | 0.0% | 0.01% | +50.0% |
| Q3 2015 | $213,000 | -20.5% | 30,844 | +1.8% | 0.01% | -14.3% |
| Q2 2015 | $268,000 | -50.8% | 30,300 | -45.2% | 0.01% | -50.0% |
| Q1 2015 | $545,000 | +20.3% | 55,250 | -7.6% | 0.01% | +7.7% |
| Q2 2014 | $453,000 | -45.1% | 59,800 | -40.7% | 0.01% | -94.1% |
| Q2 2013 | $825,000 | – | 100,891 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |